In KIRC, PGAM1 has been found to play a crucial role in tumor proliferation, and its high expression is associated with abnormal glycolysis and the formation of KIRC, making it a potential therapeutic target for cancer therapy [8, 9]. This evidence concerns the gene PGAM1 and neoplasm.